1. Home
  2. RLGT vs MDWD Comparison

RLGT vs MDWD Comparison

Compare RLGT & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radiant Logistics Inc.

RLGT

Radiant Logistics Inc.

HOLD

Current Price

$6.64

Market Cap

291.6M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.35

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLGT
MDWD
Founded
2001
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.6M
238.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RLGT
MDWD
Price
$6.64
$16.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$8.00
$37.50
AVG Volume (30 Days)
140.2K
103.9K
Earning Date
02-09-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
72.35
N/A
EPS
0.31
N/A
Revenue
$925,786,000.00
$20,932,000.00
Revenue This Year
$3.77
$15.89
Revenue Next Year
$3.51
$25.33
P/E Ratio
$21.36
N/A
Revenue Growth
16.42
6.15
52 Week Low
$5.44
$14.14
52 Week High
$7.94
$22.51

Technical Indicators

Market Signals
Indicator
RLGT
MDWD
Relative Strength Index (RSI) 56.45 34.52
Support Level $6.66 $16.32
Resistance Level $6.79 $19.70
Average True Range (ATR) 0.15 0.78
MACD 0.01 -0.26
Stochastic Oscillator 80.39 2.46

Price Performance

Historical Comparison
RLGT
MDWD

About RLGT Radiant Logistics Inc.

Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: